Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2014-09-11 05:13:49 UTC |
---|
Update Date | 2016-11-09 01:09:11 UTC |
---|
Accession Number | CHEM003688 |
---|
Identification |
---|
Common Name | Potassium Chloride |
---|
Class | Small Molecule |
---|
Description | A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives. |
---|
Contaminant Sources | - EAFUS Chemicals
- FooDB Chemicals
- HPV EPA Chemicals
- OECD HPV Chemicals
- T3DB toxins
|
---|
Contaminant Type | - Drug
- Food Toxin
- Household Toxin
- Inorganic Compound
- Natural Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
[KCL] | ChEBI | Kaliumchlorid | ChEBI | Kaon-CL 10 | ChEBI | KCl | ChEBI | Klor-CON | ChEBI | Klotrix | ChEBI | Monopotassium chloride | ChEBI | Muriate OF potash | ChEBI | Sylvite | ChEBI | K-Dur | Kegg | Kaon-CL | Kegg | Muriic acid OF potash | Generator | Chloride, potassium | MeSH | Slow-K | MeSH |
|
---|
Chemical Formula | ClK |
---|
Average Molecular Mass | 74.551 g/mol |
---|
Monoisotopic Mass | 73.933 g/mol |
---|
CAS Registry Number | 7447-40-7 |
---|
IUPAC Name | potassium chloride |
---|
Traditional Name | potassium chloride |
---|
SMILES | [Cl-].[K+] |
---|
InChI Identifier | InChI=1S/ClH.K/h1H;/q;+1/p-1 |
---|
InChI Key | WCUXLLCKKVVCTQ-UHFFFAOYSA-M |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of inorganic compounds known as alkali metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is an alkali metal. |
---|
Kingdom | Inorganic compounds |
---|
Super Class | Mixed metal/non-metal compounds |
---|
Class | Alkali metal salts |
---|
Sub Class | Alkali metal chlorides |
---|
Direct Parent | Alkali metal chlorides |
---|
Alternative Parents | |
---|
Substituents | - Alkali metal chloride
- Inorganic chloride salt
- Inorganic salt
|
---|
Molecular Framework | Not Available |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Endogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 770°C | Boiling Point | Not Available | Solubility | Freely soluble |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Not Available |
---|
Toxicity Profile |
---|
Route of Exposure | Potassium is a normal dietary constituent and under steady-state conditions the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. |
---|
Mechanism of Toxicity | Supplemental potassium in the form of high potassium food or potassium chloride may be able to restore normal potassium levels. |
---|
Metabolism | Route of Elimination: Potassium is a normal dietary constituent and, under steady-state conditions, the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine. Potassium depletion will occur whenever the rate of potassium loss through renal excretion and/or loss from the gastrointestinal tract exceeds the rate of potassium intake. |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | For use as an electrolyte replenisher and in the treatment of hypokalemia. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, of if potassium is administered too rapidly intravenously, potentially fatal hyperkalemia can result. It is important to recognize that hyperkalemia is usually asymptomatic and may be manifested only by an increased serum potassium concentration (6.5-8.0 mEq/L) and characteristic electrocardiographic changes (peaking of T-waves, loss of P-wave, depression of S-T segment, and prolongation of the QT interval). Late manifestations include muscle paralysis and cardiovascular collapse from cardiac arrest (9-12 mEq/L). |
---|
Symptoms | Not Available |
---|
Treatment | EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration. |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00761 |
---|
HMDB ID | HMDB0303551 |
---|
FooDB ID | FDB015439 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | KCL |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Potassium_Chloride |
---|
Chemspider ID | 4707 |
---|
ChEBI ID | 32588 |
---|
PubChem Compound ID | Not Available |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Fritz Hagedorn, Gerd Peuschel, Arno Singewald, “Method for the production of potassium chloride with K.sub.2 O content of more than 55 weight percent.” U.S. Patent US5057208, issued July, 1955. |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|